Tech Company Financing Transactions
Ception Therapeutics Funding Round
Ception Therapeutics, based in Malvern, secured $14.7 million from Greenlight Capital.
Transaction Overview
Company Name
Announced On
5/31/2007
Transaction Type
Venture Equity
Amount
$14,700,000
Round
Series C
Investors
Proceeds Purpose
Steve Tullman, President and CEO of Ception Therapeutics said, "This additional strategic capital provides an extended financial runway for our lead biologic program, as well as our other development and discovery programs. We are delighted that our current investors decided to provide additional capital to the company."
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
101 Lindenwood Dr. 400
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Overview
Ception Therapeutics is an emerging biopharmaceutical company focused on the discovery and development of novel products to address areas of unmet medical need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Tullman
Chief Financial Officer
Doug Gessl
Vice President
Jeffrey Wilkins
VP - Bus. Development
Kelly Copeland
VP - Operations
Evan Dick
VP - Product Management
Jeffrey Shaver
VP - R & D
Tim Henkel
VP - Regulatory Affairs
Patricia Cleveland
Browse more venture capital transactions:
Prev: 5/31/2007: Oberon Media venture capital transaction
Next: 5/31/2007: Powerit Holdings venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs